As the clinical trials industry evolves, technology innovations have lagged. The same process of collecting source on paper and transcribing into EDC has lingered for decades. A survey conducted by SCRS, Clinical Ink and Center Watch revealed how eSource technology reduces site workload, decreases data errors, and improves efficiencies. The objective of this webinar is to discuss the survey and how eSource can be used to address the inefficiencies in site data collection, reduce redundant and administrative tasks, enable remote/centralized source data review and provide a better clinical trial experience for all stakeholders in the clinical trial.
Join our webinar, presented by the CEO of Clinical Ink, Ed Seguine, as he discusses the survey findings and what this information means for sites today and the potential impact eSource can have on your studies. Learn how eSource is reshaping the time and cost efficiencies of modern clinical trials.
Ed Seguine, Chief Executive Officer, Clinical Ink
As Chief Executive Officer (CEO) of Clinical Ink, Ed Seguine brings more than18 years of experience as a clinical technology executive at Big Pharma and start-up organizations. Ed joined Clinical Ink in late 2009 with the goal of creating a company that would eliminate the problems caused by the current paper-based processes and technologies.
Prior to joining Clinical Ink, Mr. Seguine was General Manager, Trial Planning at Medidata Solutions, where he managed the acquisition integration activities and product positioning prior to the company’s IPO. He also served as CEO of Fast Track Systems where he oversaw the turn-around process and established the early commercial successes for a novel product that became the rationale for acquisition by Medidata Solutions. Prior to Fast Track, Ed was a founding manager of the Eli Lilly & Co. venture capital funds—e.Lilly and Lilly Bioventures—focusing on technology and biotech/device companies.
Ed has been intimately involved with key industry initiatives, including CDISC and eClinical Forum. He is a frequent presenter at industry events and publishes regularly. Ed earned an MBA from Indiana University-Bloomington and a bachelor’s degree in finance from Brigham Young University.
Doug Pierce, President & Co-Founder, Clinical Ink
Doug Pierce co-founded Clinical Ink in 2007 to revolutionize clinical trials by eliminating the complexities and costs associated with paper-based data capture processes. In his role as President and Co-Founder, Mr. Pierce brings 20+ years of experience in digital forms technology and mobile data capture to lead the strategic direction, development and evolution of Clinical Ink’s eSource Suite.
Prior to Clinical Ink, Mr. Pierce co-founded Piermed, Inc., a medical documentation solutions company specializing in data capture for primary care settings. Offering an alternative to the inefficient data capture methods traditionally used by physicians, Mr. Pierce developed a series of electronic forms to effectively streamline medical data capture and retrieval. Under Mr. Pierce’s leadership, Piermed, Inc. grew from a small regional start-up into an established corporation with customers in 48 states.
A pioneer of eSource technology for the life sciences industry, Doug is noted for giving the first eSource presentation to the U.S. Food and Drug Administration in 2008. He earned a master’s degree and bachelor’s degree in philosophy from the University of Montana.
Who Should Attend?
- Pharma/Biotech Sr. Management Personnel
- CRO Sr. Management Personnel
- Data Managers
- Clinical Trial Managers
What You Will Learn
- Survey results on how eSource technology reduces site workload, decreases data errors, and improves efficiencies in clinical trials
- How eSource can be used to address the inefficiencies in site data collection, reduce redundant and administrative tasks, enable remote/centralized source data review and provide a better clinical trial experience
- The potential impact eSource can have on your studies
Founded in 2007, Clinical Ink® is transforming clinical development with innovative technologies that make clinical research easier for sites, sponsors and patients. Clinical Ink’s SureSource® comprehensive platform directly captures eSource data and documents and improves patient engagement by focusing on the critical moments that matter when executing the protocol. Clinical Ink maintains offices in Cambridge, MA, Winston-Salem, NC, and Philadelphia, PA. Find more at www.clinicalink.com.